The in vivo estrogenic potency of
zearalenone (ZEA), a
mycotoxin produced by different strains of Fusarium fungi, and its metabolites (alpha- and
beta-zearalenol), have been studied in fish. Estrogenicity was evaluated using an in vitro competitive receptor binding assay and in vivo induction of vitellogenesis and zonagenesis, two
estrogen receptor (ER)-mediated responses that are integral aspects of fish oogenesis. The ER binding affinities of
alpha-zearalenol and ZEA in rainbow trout (Oncorhynchus mykiss) were approximately 1/150 and 1/300 to that of
estradiol, respectively. Juvenile salmon (Salmo salar) were exposed to a single
intraperitoneal injection of ZEA,
alpha-zearalenol and
beta-zearalenol (each at 1 and 10 mg/kg) and compared to fish injected with
estradiol-17 beta (E2; 5 mg/kg) and controls. Using indirect
enzyme-linked
immunosorbent assay (ELISA) with homologous
antibodies, a dose-dependent induction of
vitellogenin (Vtg) and eggshell
zona radiata
proteins (Zr-
proteins) were observed 7 days after exposure to ZEA and
alpha-zearalenol.
beta-Zearalenol did not elevate plasma Vtg levels, but a non-significant elevation of plasma Zr-
proteins levels was observed at the highest dose (10 mg/kg). Generally,
alpha-zearalenol and ZEA possess estrogenic potencies that are approximately 50% compared to that of E2, and their order of estrogenic potency (in both in vitro receptor competitive binding and in vivo induction of Vtg and Zr-
proteins levels) is:
alpha-zearalenol > ZEA >
beta-zearalenol. Our results show that blood plasma analysis of Vtg and Zr-
proteins levels provides a suitable in vivo fish model for assessing the estrogenic potencies of ZEA and its metabolites.